Patent · US Expired

Etoposide analogues

US5132322A · kind A · utility

15Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 1989
Grant dateJul 21, 1992
Priority date
Expiry dateSep 12, 2009

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D493/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds that are analogs of etoposide and exhibit antitumor activity are disclosed. The compounds of the present invention have the following formula: ##STR1## where: R.sub.1 is .beta.-OCH.sub.2 CH.sub.2 NH.sub.2 .beta.-NHCH(CH.sub.3)CH.sub.2 OH, .beta.-NHCH.sub.2 CH(CH.sub.3)OH, .beta.-Cl, .beta.-Br, .beta.-OH, .alpha.-OH, .beta.-NH, .alpha.-NH.sub.2, .beta.-NHCH.sub.2 CH.sub.2 OH, .alpha.-NHCH.sub.2 CH.sub.2 OH, .beta.-NHCH.sub.2 CH.sub.2 CH.sub.3, .beta.-NHCH.sub.2 CH.sub.2 OCH.sub.3, .beta.-NHCH.sub.2 CH.dbd.CH.sub.2, .beta.-NHCH.sub.2 CH(OH)CH.sub.3, .beta.-NHCH.sub.2 CH.sub.2 CH.sub.2 OH, .beta.-OCH.sub.2 CH.sub.2 OH, ##STR2## R.sub.2 is H, or Br; R.sub.1 is H, or Br; PA0 R.sub.4 is H, or Br; PA0 R.sub.5 is H, or Br; and PA0 R.sub.6 is H, or --CH.sub.3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.